VI
CNMD icon

Versor Investments’s CONMED CNMD Stock Holding History

Versor Investments’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,726
Closed -$354K – 155
2025
Q4 		$354K Buy
8,726
+2,104
+32% +$91.5K 0.06% 421
2025
Q3 		$311K Buy
6,622
+2,434
+58% +$126K 0.06% 477
2025
Q2 		$218K Sell
4,188
-9,245
-69% -$507K 0.04% 640
2025
Q1 		$811K Buy
13,433
+5,765
+75% +$372K 0.13% 268
2024
Q4 		$525K Sell
7,668
-1,038
-12% -$72.3K 0.09% 374
2024
Q3 		$626K Buy
+8,706
New +$614K 0.1% 345
2024
Q2 		– Sell
-7,962
Closed -$638K – 754
2024
Q1 		$638K Buy
7,962
+5,370
+207% +$479K 0.13% 262
2023
Q4 		$284K Sell
2,592
-2,117
-45% -$219K 0.06% 544
2023
Q3 		$475K Buy
+4,709
New +$541K 0.1% 331
2020
Q1 		– Sell
-2,600
Closed -$291K – 264
2019
Q4 		$291K Buy
+2,600
New +$277K 0.01% 268

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Versor Investments's CNMD Position: Q1 2026 in Review

Versor Investments sold out of CONMED (CNMD) in Q1 2026, closing a stake of 8,726 shares — an estimated $354K sold.

Versor Investments first reported a position in CNMD in Q4 2019 and held it in 10 quarters. The position peaked at $811K in Q1 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Versor Investments reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 8,726 CONMED shares in Q1 2026, an estimated $354K.
  • Versor Investments first reported a position in CONMED in Q4 2019 and held it in 10 quarters.
  • Versor Investments's CONMED position peaked at $811K in Q1 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.